As transactions increasingly cross international borders, O’Melveny is well equipped to help clients successfully negotiate the issues and complexities that inevitably arise. We handle inbound and outbound tax issues in matters that range from financings to investment funds to joint ventures and mergers and acquisitions.

Working seamlessly with teams across O’Melveny’s broad transactions practice, we leverage our thorough knowledge of complex tax laws to devise strategic and pragmatic solutions tailored to our clients’ business priorities.

One of the few international law firms with our own US, UK, and Chinese international tax capabilities, we also have strong working relationships with leading independent law firms across Europe, Asia, and in many other geographies to assist our clients in structuring and executing transactions in jurisdictions where we do not have offices. In such cases, we act as co-counsel or coordinate the work according to client preference and the particular needs of the transaction.

Lionsgate Entertainment Corp.

O’Melveny represented Lionsgate in its multiyear slate co-financing deal with Hunan TV & Broadcast Intermediary Co. Ltd. in reportedly the biggest investment in Hollywood by a Chinese company to date. Read

Montage Technology Group Limited

O’Melveny represented Montage Technology Group Limited, a global fabless provider of analog and mixed-signal semiconductor solutions based in China, in connection with a merger agreement with Shanghai Pudong Science and Technology Investment Co., Ltd. in a US$693 million going private transaction. Read
    • 7 Days Group Holdings Limited
    • Axiom Asia Private Capital
    • Canada Pension Plan Investment Board
    • China Investment Corporation
    • Coller Investment Management Limited
    • GIC Private Limited
    • Goldman Sachs & Co.
    • Helios Investment Group
    • Honeywell International Inc.
    • Korea Investment Corporation
    • Lions Gate Entertainment Corp.
    • Montage Technology Group Limited
    • Safe Investment Company Limited
    • Temasek Holding (Private) Limited
    • UBS AG
    • WuXi PharmaTech